MAPT and Alzheimer disease: The aim of this study was to assess concentrations of Klotho in CSF and plasma and to correlate these findings with KL-VS heterozygosity status to explore a possible association with amyloid and tau burden among a control group of cognitively healthy elderly individuals and patients with AD.